Wellness
Paul McKenzie to take the reins of CSL as new CEO in March
Beginning in March 2023, CSL will have a new CEO and board executive director in Paul McKenzie, who spent three years as COO after jumping ship from Biogen.
Paul…
Beginning in March 2023, CSL will have a new CEO and board executive director in Paul McKenzie, who spent three years as COO after jumping ship from Biogen.
Paul PerreaultMcKenzie is taking over from Paul Perreault, a longtimer at CSL. Perreault served as CEO for 10 years and over 25 years total with the company. But March won’t be the end for Perreault: He’ll stay on as an advisor until officially retiring in September 2023.
McKenzie is taking over at CSL on the heels of a success after the November approval of Hemgenix, the world’s first gene therapy for hemophilia B. It’s also the US’ most expensive single-use gene therapy with the price listed at $3.5 million.
“I look forward to continuing our momentum and engaging closely with the Board, our leadership team, 30,000 colleagues, and other stakeholders to serve patients and public health around the world,” McKenzie said in a statement. “We will continue focusing on executing our 2030 strategy, investing in innovation, and continue achieving sustainable and profitable growth.”
Lion’s Mane Mushroom: History, Benefits, and Adaptogen Properties
Explore the intriguing world of Lion’s Mane Mushroom in our comprehensive guide. Dive into its unique properties, historical significance, and myriad health…
AI can already diagnose depression better than a doctor and tell you which treatment is best
Artificial intelligence (AI) shows great promise in revolutionizing the diagnosis and treatment of depression, offering more accurate diagnoses and predicting…
Reasons You should Get this: Neptune Wellness Solutions Inc (NASDAQ:NEPT), WeTrade Group Inc. (NASDAQ:WETG)
NEPT has seen its SMA50 which is now -9.28%. In looking the SMA 200 we see that the stock has seen a -92.25%. WETG has seen its SMA50 which is …
The…
